Recently, it was reported that concomitant hemodialysis (HD) in @entity298 ( @entity298 ) @entity1 facilitated continuation of @entity298 treatment and mitigated the deterioration of peritoneal function in @entity1 with uremic symptoms and excess body fluid associated with @entity177 . To determine the effect of combined HD and @entity298 on @entity1 and technique survival, we undertook a retrospective cohort study of @entity1 who underwent @entity298 at Saitama Medical University Hospital between 1995 and 2010. We compared @entity1 who started @entity298 during 1995 2002 with those who started during 2003- 2010. Because our center started a new strategy of supplementing @entity298 with once-weekly HD in 2000, the effects of combination therapy could be determined by comparing the data obtained during the two periods. The 440 @entity1 (274 @entity1 , 166 @entity1 ) who started @entity298 during the study period had a mean age of 60.2 +/- 73 years. The mean age was significantly higher in the 2003 - 2010 group than in the 1995 - 2002 group. Using a Kaplan-Meier plot, we observed a significant difference in technique survival (p < 0.001). The technique survival rate at 3 and 5 years was, respectively, 89% and 74% in the 2003-2010 group and 68% and 35% in the 1995 - 2002 group (p < 0.05). Cumulative @entity1 survival at 3 and 5 years was, respectively, 87% and 72% in the 2003 - 2010 group and 69% and 51% in the 1995 - 2003 group (p < 0.01). @entity1 and technique survival were significantly improved in @entity298 @entity1 receiving the combination of HD and @entity298 .

Long-term survival benefits of combined hemodialysis and XXXX .

@entity1 :: ('9606', 'Species') :: ['women', 'patients', 'patient', 'Patient', 'men'] @entity177 :: ('MESH:D051437', 'Disease') :: ['loss of residual renal function'] @entity298 :: ('MESH:D010538', 'Disease') :: ['peritoneal dialysis', 'PD']
@entity298 :: (MESH:D010538,Disease) :: ['peritoneal dialysis']
